Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Purely Proteins was a specialist biotechnology company based in the United Kingdom that focused on the production and purification of high-quality recombinant proteins. The company served the global pharmaceutical and biotech sectors by providing essential reagents for structural biology, drug discovery, and assay development. Purely Proteins was particularly recognized for its expertise in expressing and purifying complex or "difficult" proteins that were often inaccessible through standard commercial routes. In 2008, the company was acquired by MIP Technologies, a Swedish firm specializing in molecularly imprinted polymers, which was subsequently integrated into Biotage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purely Proteins.